The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
B Xu, S Li, B Kang, J Zhou - Cardiovascular diabetology, 2022 - Springer
Type 2 diabetes mellitus (T2DM) is a chronic, complex metabolic disease characterized by
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
chronic hyperglycemia causing from insufficient insulin signaling because of insulin …
The crucial role and mechanism of insulin resistance in metabolic disease
X Zhao, X An, C Yang, W Sun, H Ji… - Frontiers in endocrinology, 2023 - frontiersin.org
Insulin resistance (IR) plays a crucial role in the development and progression of
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
metabolism-related diseases such as diabetes, hypertension, tumors, and nonalcoholic fatty …
SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients
P Mone, F Varzideh, SS Jankauskas, A Pansini… - …, 2022 - Am Heart Assoc
Background: Frailty is a multidimensional condition often diagnosed in older adults with
hypertension and diabetes, and both these conditions are associated with endothelial …
hypertension and diabetes, and both these conditions are associated with endothelial …
Insulin resistance and cardiovascular disease
CE Kosmas, MD Bousvarou… - Journal of …, 2023 - journals.sagepub.com
Insulin resistance (IR) and cardiovascular disease (CVD) represent two universal public
health hazards, especially in today's Western societies. A causal-effect relationship has …
health hazards, especially in today's Western societies. A causal-effect relationship has …
[HTML][HTML] Diabetes mellitus—Progress and opportunities in the evolving epidemic
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads
to complications that reduce quality of life and increase mortality. Diabetes pathophysiology …
to complications that reduce quality of life and increase mortality. Diabetes pathophysiology …
Cardiorenal protection of SGLT2 inhibitors—perspectives from metabolic reprogramming
YM Gao, ST Feng, Y Wen, TT Tang, B Wang, BC Liu - EBioMedicine, 2022 - thelancet.com
Summary Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed as a novel
class of anti-hyperglycaemic drugs, have been shown to significantly improve metabolic …
class of anti-hyperglycaemic drugs, have been shown to significantly improve metabolic …
Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase
Insulin action in the human brain modulates eating behaviour, whole-body metabolism and
body fat distribution,. In particular, brain insulin action increases whole-body insulin …
body fat distribution,. In particular, brain insulin action increases whole-body insulin …
[HTML][HTML] Exercise restores brain insulin sensitivity in sedentary adults who are overweight and obese
S Kullmann, T Goj, R Veit, L Fritsche, L Wagner… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Insulin resistance of the brain can unfavorably affect long-term weight
maintenance and body fat distribution. Little is known if and how brain insulin sensitivity can …
maintenance and body fat distribution. Little is known if and how brain insulin sensitivity can …
Metformin improves cognitive impairment in patients with schizophrenia: associated with enhanced functional connectivity of dorsolateral prefrontal cortex
T Shao, J Huang, Y Zhao, W Wang, X Tian… - Translational …, 2023 - nature.com
Cognitive impairment is a core feature of schizophrenia, which is aggravated by
antipsychotics-induced metabolic disturbance and lacks effective pharmacologic treatments …
antipsychotics-induced metabolic disturbance and lacks effective pharmacologic treatments …
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
X Chen, S Chen, Z Li, R Zhu, Z Jia, J Ban… - Frontiers in …, 2023 - frontiersin.org
Objective: Based on the 4D label-free phosphoproteomic technique, we examined the
differences in cognitive function and hippocampal phosphorylated protein expression in …
differences in cognitive function and hippocampal phosphorylated protein expression in …